Retroviral insertional mutagenesis of a herpesvirus: A marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication

Avian Diseases

Volumn 41, Issue 2, 1997, Pages 407-421

  Witter, R L ^a   Li, Deshan ^b   Jones, Dan ^b   Lee, L F ^a   Kung, H J ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attenuation; Insertional mutagenesis; Marek's disease; Mutant; Reticuloendotheliosis; Virulence; virus

Indexed keywords

ANIMALIA; AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE; RETICULOENDOTHELIOSIS VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0031128028     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.2307/1592197     Document Type: Article

References (46)

1. Becker, Y., E. Tabor, Y. Asher, I. Davidson, M. Malkinson, and R. L. Witter. PCR detection of amplified 132 bp repeats in Marek's disease virus type 1 (MDV-1) DNA can serve as an indicator for critical genomic rearrangement leading to the attenuation of virus virulence. Virus Genes 7:277-287. 1993.
2. Calnek, B. W., S. B. Hitchner, and H. K. Adldinger. Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys. Appl. Microbiol. 20:723-726. 1970.
3. Chen, C. H., L. L. Ager, G. L. Gardand, and M. D. Cooper. Identification of a T3/T cell receptor complex in chicken. J. Exp. Med. 164:375-380. 1986.
4. Chen, C. H., and M. D. Cooper. Identification of cell surface molecules on chicken lymphocytes with monoclonal antibodies. In: Avian immunology, basis and practice. A. Toivanen and P. Toivanen, eds. CRC Press, Boca Raton. pp. 137-154. 1987.
5. Chung, K. S., and H. S. Lillehoj. Development and functional characterization of monoclonal antibodies recognizing chicken lymphocytes with natural killer cell activity. Vet. Immunol. Immunopathol. 28: 351-363. 1991.
6. Churchill, A. E., R. C. Chubb, and W. Baxendale. The attenuation with loss of oncogenicity of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol. 4:557-564. 1969.
7. Cook, M. K. Cultivation of filterable agent associated with Marek's disease. J. Natl. Cancer Inst. 43:203-212. 1969.
8. Cui, Z. Z., L. F. Lee, R. F. Silva, and R. L. Witter. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes. J. Immunol. 136: 4237-4242. 1986.
9. Cui, Z. Z., L. F. Lee, E. J. Smith, R. L. Witter, and T. S. Chang. Monoclonal-antibody-mediated enzyme-linked immunosorbent assay for detection of reticuloendotheliosis viruses. Avian Dis. 32:32-40. 1988.
10. Fukuchi, K., A. Tanaka, L. W. Schierman, R. L. Witter, and M. Nonoyama. The structure of Marek's disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc. Natl. Acad. Sci. USA 82:751-754. 1985.
11. Games, P. A. An improved t table for simultaneous control of g contrasts. J. Am. Stat. Assoc. 72: 531-534. 1977.
12. Isfort, R. J., D. Jones, R. G. Kost, R. L. Witter, and H. Kung. Retrovirus insertion into herpesvirus in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:991-995. 1992.
13. Isfort, R. J., Z. Qian, D. Jones, R. F. Silva, R. L. Witter, and H. Kung. Integration of multiple chicken retroviruses into multiple chicken herpesviruses: herpesviral gD as a common target of integration. Virology 203:125-133. 1994.
14. Isfort, R. J., R. L. Witter, and H. Kung. Retrovirus insertion into herpesvirus. Trends Microbiol. 2:174-178. 1994.
15. Jones, D., P. Brunovskis, R. Witter, and H. Kung. Retroviral insertional activation in a herpesvirus: transcriptional activation of Us genes by an integrated long terminal repeat in a Marek's disease virus clone. J. Virol. 70:2460-2467. 1996.
16. Jones, D., R. J. Isfort, R. L. Witter, R. G. Kost, and H. Kung. Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences. Proc. Natl. Acad. Sci. USA 90:3855-3859. 1993.
17. Kit, S., and M. Kit. Genetically engineered herpesvirus vaccines - accomplishments in pigs and prospects in humans. Prog. Med. Virol. 38:128-166. 1991.
18. Konobe, T., T. Ishikawa, K. Takaku, K. Ikuta, N. Kitamoto, and S. Kato. Marek's disease virus and herpesvirus of turkey noninfective to chickens, obtained by repeated in vitro passages. Biken J. 22:103-107. 1979.
19. Kost, R. G., D. Jones, R. J. Isfort, R. L. Witter, and H. Kung. Retrovirus insertion into herpesvirus: characterization of a Marek's disease virus har-boring a solo LTR. Virology 192:161-169. 1993.
20. Kudo, Y., M. Mattori, T. Mikami, and M. Onuma. The effect of CD4+ or CD8+ T cell depletion in chickens for the development of Marek's disease lymphoma and vaccine protection. In: 4th International Symposium on Marek's Disease, 19th World's Poultry Congress, Vol. 1. World's Poultry Science Assoc., Amsterdam. pp. 246-250. 1992.
21. Lee, L. F. In vitro assay of mitogen stimulation of avian peripheral lymphocytes. Avian Dis. 18: 602-609. 1974.
22. Lee, L. F., X. Liu, and R. L. Witter. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J. Immunol. 130:1003-1006. 1983.
23. Lee, L. F., J. M. Sharma, K. Nazerian, and R. L. Witter. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys. Infect. Immun. 21:474-479. 1978.
24. Maotani, K., A. Kanamori, K. Ikuta, S. Ueda, S. Kato, and K. Hirai. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J. Virol. 58:657-660. 1986.
25. Nazerian, K. Attenuation of Marek's disease virus and study of its properties in two different cell cultures. J. Natl. Cancer Inst. 44:1257-1267. 1970.
26. Rispens, B. H., J. Van Vloten, N. Mastenbroek, H. J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16: 108-125. 1972.
27. Rivas, A. L., and J. Fabricant. Indications of immunodepression in chickens infected with various strains of Marek's disease virus. Avian Dis 32:1-8. 1988.
28. Ross, L. J. N., M. M. Binns, M. J. Sanderson, and K. A. Schat. Alterations in DNA sequence and RNA transcription of the BamHI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus. Virus Genes 7:33-51. 1993.
29. Schat, K. A., and B. W. Calnek. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082. 1978
30. Schat, K. A., B. W. Calnek, J. Fabricant, and D. L. Graham. Pathogenesis of infection with attenuated Marek's disease virus strains. Avian Pathol. 14: 127-146. 1985.
31. Sevoian, M., D. M. Chamberlain, and F. T. Counter. Avian lymphomatosis. I. Experimental reproduction of the neural and visceral forms. Vet. Med. 57:500-501. 1962.
32. Silva, R. F. Differentiation of pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome. Avian Dis. 36:521-528. 1992.
33. Silva, R. F., and R. L. Witter. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage. J. Virol. 54:690-696. 1985.
34. Smith, E. J., A. M. Fadly, and W. Okazaki. An enzyme-linked immunosorbent assay for detecting avian leukosis-sarcoma viruses. Avian Dis. 23: 698-707. 1979.
35. Steel, R. G. D., and J. H. Torrie. Principles and procedures of statistics. McGraw-Hill Book Company, Inc., New York. 1960.
36. Stephens, E. A., R. L. Witter, L. F. Lee, J. M. Sharma, K. Nazerian, and B. M. Longenecker. Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable virus. J. Natl. Cancer Inst. 57:865-874. 1976.
37. Theis, G. A., R. A. McBride, and L. W. Schierman. Depression of in vitro responsiveness to phytohemagglutinin in spleen cells cultured from chickens with Marek's disease. J. Immunol. 115:848-853. 1975.
38. Witter, R. L. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy. Avian Dis. 31:752-765. 1987.
39. Witter, R. L. Protective synergism among Marek's disease vaccine viruses. In: Advances in Marek's disease research. S. Kato, T. Horiuchi, T. Mikami, and K. Hirai, eds. Japanese Association on Marek's Disease, Osaka, Japan. pp. 398-404. 1988.
40. Witter, R. L. Safety and comparative efficacy of the CVI988/Rispens vaccine strain. In: 4th International Symposium on Marek's Disease, 19th Worlds Poultry Congress, Vol. 1. World's Poultry Science Assoc., Amsterdam. pp. 315-319. 1992.
41. Witter, R. L., L. F. Lee, and A. M. Fadly. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's dis-ease virus. Avian Dis. 39:269-284. 1995.
42. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538. 1970.
43. Witter, R. L., and L. Offenbecker. Nonprotective and temperature-sensitive variants of Marek's disease vaccine viruses. J. Natl. Cancer Inst 62:143-151. 1979.
44. Witter, R. L., H. G. Purchase, and G. H. Burgoyne. Peripheral nerve lesions similar to those of Marek's disease in chickens inoculated with reticuloendotheliosis virus. J. Natl. Cancer Inst. 45:567-577. 1970.
45. Witter, R. L., J. M. Sharma, and A. M. Fadly. Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens. Avian Dis. 24:210-232. 1980.
46. Zhu, G., T. Ojima, T. Hironaka, T. Ihara, N. Mizukoshi, A. Kato, S. Ueda, and K. Hirai. Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification. Avian Dis. 36: 637-645. 1992.